Abstract
Clinical effectiveness evidence is a key component of companies’ health technology submissions to the UK National Institute for Health and Care Excellence (NICE) and has to be sought via systematic literature reviews (SLRs). To identify where, and better understand why, NICE Evidence Review Groups (ERGs) have criticised SLRs on clinical effectiveness (clinical SLRs), we reviewed their responses to recent oncology-related submissions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
